Tag: facility in Songdo
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
